BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma N, Upadhayay S, Shandilya A, Sahu R, Singh A, Rajkhowa B, Mehan S. Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats. Phytomedicine Plus 2021;1:100051. [DOI: 10.1016/j.phyplu.2021.100051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Khera R, Mehan S, Bhalla S, Kumar S, Alshammari A, Alharbi M, Sadhu SS. Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism. Molecules 2022;27:889. [DOI: 10.3390/molecules27030889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
2 Singh A, Upadhayay S, Mehan S. Inhibition of c-JNK/p38MAPK signaling pathway by Apigenin prevents neurobehavioral and neurochemical defects in ethidium bromide-induced experimental model of multiple sclerosis in rats: Evidence from CSF, blood plasma and brain samples. Phytomedicine Plus 2021;1:100139. [DOI: 10.1016/j.phyplu.2021.100139] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gupta R, Mehan S, Sethi P, Prajapati A, Alshammari A, Alharbi M, Al-mazroua HA, Narula AS. Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder. Brain Sciences 2022;12:342. [DOI: 10.3390/brainsci12030342] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rajkhowa B, Mehan S, Sethi P, Prajapati A. Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions. Neurotox Res. [DOI: 10.1007/s12640-022-00480-z] [Reference Citation Analysis]
5 Shandilya A, Mehan S, Kumar S, Sethi P, Narula AS, Alshammari A, Alharbi M, Alasmari AF. Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity. Molecules 2022;27:3878. [PMID: 35745001 DOI: 10.3390/molecules27123878] [Reference Citation Analysis]
6 Upadhayay S, Mehan S. Targeting Nrf2/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions. Brain Disorders 2021;3:100019. [DOI: 10.1016/j.dscb.2021.100019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang M, Yu H, Hu J, Zhao Z, Liu L, Yang G, Wang T, Han G, Song S. Therapeutic carrier based on solanesol and hyaluronate for synergistic tumor treatment. Int J Biol Macromol 2022;201:20-8. [PMID: 34998870 DOI: 10.1016/j.ijbiomac.2021.12.194] [Reference Citation Analysis]